Treatment Review 2026
Retatrutide
Triple agonist (GLP-1/GIP/glucagon) in late-stage development for obesity treatment.
$300 - $900
Per month
Think of it as turning down hunger signals so eating less feels easier.
Detailed
Targets multiple incretin and glucagon pathways to drive appetite and energy-balance changes.
Investigational protocols vary; clinical titration frameworks still evolving.
Use Cases
- nausea
- GI upset
- increased heart rate
Investigational; not broadly approved for routine prescribing.
Providers below currently advertise relevant glp-1 programs.
Provider-tracked monthly range: $30 - $699
What is Retatrutide usually used for?
Retatrutide is typically discussed for advanced weight loss, metabolic optimization. 26 tracked providers currently list options in this category.
How is Retatrutide commonly dosed?
Common protocols reported by clinics and patients: Investigational protocols vary; clinical titration frameworks still evolving. Always individualize with a licensed clinician.
Is Retatrutide legal in the U.S.?
Investigational; not broadly approved for routine prescribing.
What side effects should I watch for with Retatrutide?
Commonly reported effects include nausea, GI upset, increased heart rate. Escalate any severe or persistent symptoms to your care team quickly.